Clever Leaves Expands Presence in Brazil Through Partnership with Hypera Pharma
April 18 2023 - 8:30AM
Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW), a global
medicinal cannabis company, announced today that it has entered
into a five-year agreement with Hypera Pharma (B3: HYPE3), a
leading pharmaceutical company in Brazil, to supply Clever Leaves’
CBD-dominant oral solutions with the aim of treating various
medical conditions and prescribing to Brazilian patients.
Hypera Pharma is one of Brazil’s largest
pharmaceutical companies in net sales with expertise in the
registration, commercialization, and distribution of prescription
medicines as well as over-the-counter and skin care products.
Clever Leaves’ leadership position in the region makes it uniquely
equipped to enter and thrive in the Brazilian market, meeting all
the regulatory and product quality requirements. The CBD products
manufactured under this partnership have been registered under RDC
327 framework and are already being sold into distribution channels
such as pharmacies and drugstores. The companies plan to continue
the process with additional products.
“Hypera Pharma’s history, innovative vision,
capabilities, focus on high-quality, and commitment to sustainable
growth is aligned with Clever Leaves’ values, making them an ideal
partner to promote and scale patient access to safe,
pharmaceutical-grade cannabis products in Brazil. Expanding our
presence in Brazil, a market that prioritizes patient treatment by
enabling research and development to ensure technical and quality
standards, will open doors for potential new developments and is
further evidence of how our platform can support the global
pharmaceutical industry by allowing it to engage in the world of
cannabis-based therapies with patient safety and product quality at
the forefront,” said Andres Fajardo, CEO of Clever Leaves.
About Clever Leaves Holdings
Inc.Clever Leaves is a global medicinal cannabis company.
Its operations in Colombia produce cannabinoid active
pharmaceutical ingredients (API) and finished products in flower
and extract form to a growing base of B2B customers around the
globe. Clever Leaves aims to disrupt the traditional cannabis
production industry by leveraging environmentally sustainable,
ESG-friendly, industrial-scale and low-cost production methods,
with the world’s most stringent pharmaceutical quality
certifications. For more information, please
visit https://cleverleaves.com/
Press Contacts:Rich DiGregorioKCSA Strategic
Communications+1-856-889-7351cleverleaves@kcsa.com
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Clever Leaves (NASDAQ:CLVR)
Historical Stock Chart
From Jul 2023 to Jul 2024